Citadel Advisors
KZIA

Citadel Advisors’s Kazia Therapeutics KZIA Stock Holding History

Citadel Advisors’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,210
Closed -$26K – 14982
2024
Q3 		$26K Buy
1,210
+1,119
+1,230% +$22.3K ﹤0.01% 12568
2024
Q2 		$1.04K Buy
+91
New +$1.35K ﹤0.01% 13870
2024
Q1 		– Sell
-256
Closed -$5.75K – 15072
2023
Q4 		$5.75K Buy
+256
New +$7.49K ﹤0.01% 13405
2022
Q3 		– Sell
-455
Closed -$50.9K – 13157
2022
Q2 		$95K Buy
+455
New +$140K ﹤0.01% 11465
2021
Q4 		– Sell
-352
Closed -$176K – 14331
2021
Q3 		$202K Buy
352
+96
+38% +$47.2K ﹤0.01% 11965
2021
Q2 		$126K Buy
+256
New +$135K ﹤0.01% 12694
2019
Q4 		– Sell
-256
Closed -$49K – 9449
2019
Q3 		$49K Sell
256
-153
-37% -$20.9K ﹤0.01% 8711
2019
Q2 		$49K Buy
+409
New +$62.9K ﹤0.01% 8735
2017
Q3 		– Sell
-90
Closed -$16K – 7789
2017
Q2 		$16K Buy
90
+26
+41% +$4.91K ﹤0.01% 7331
2017
Q1 		$18K Buy
+64
New +$20.2K ﹤0.01% 7273
2016
Q4 		– Sell
-88
Closed -$35K – 7579
2016
Q3 		$35K Buy
+88
New +$34.3K ﹤0.01% 6931
2015
Q3 		– Sell
-61
Closed -$49K – 9071
2015
Q2 		$49K Buy
+61
New +$69.2K ﹤0.01% 7668
2014
Q2 		– Sell
-63
Closed -$52K – 8135
2014
Q1 		$52K Buy
+63
New +$53.7K ﹤0.01% 6752

Other funds holding KZIA

MCM
MAI Capital Management Independence, Ohio $17.7B AUM 18.87% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
RhumbLine Advisers
RhumbLine Advisers Boston, Massachusetts $117B AUM 29.66% 1-Year Est. Return
Citigroup
Citigroup New York $235B AUM 32.99% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
AF
Allworth Financial Folsom, California $24.7B AUM 15.55% 1-Year Est. Return

Citadel Advisors's KZIA Position: Q4 2024 in Review

Citadel Advisors sold out of Kazia Therapeutics (KZIA) in Q4 2024, closing a stake of 1,210 shares — an estimated $26K sold.

Citadel Advisors first reported a position in KZIA in Q1 2014 and held it in 13 quarters. The position peaked at $202K in Q3 2021. 10 funds tracked by Wall St. Rank hold KZIA as of Q4 2024.

  • Citadel Advisors reported no remaining Kazia Therapeutics position as of Q4 2024 after selling out during the quarter.
  • Citadel Advisors sold 1,210 Kazia Therapeutics shares in Q4 2024, an estimated $26K.
  • Citadel Advisors first reported a position in Kazia Therapeutics in Q1 2014 and held it in 13 quarters.
  • Citadel Advisors's Kazia Therapeutics position peaked at $202K in Q3 2021.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q4 2024.

Based on Citadel Advisors's 13F filing for Q4 2024, filed 14 Feb 2025.